Peregrine Pharmaceuticals CEO Nicholas Green's 2022 pay jumps 117% to $6.2M
Peregrine Pharmaceuticals reports 2022 executive compensation
By ExecPay News
Published: August 29, 2022
Peregrine Pharmaceuticals reported fiscal year 2022 executive compensation information on August 29, 2022.
In 2022, three executives at Peregrine Pharmaceuticals received on average a compensation package of $3.2M, a 106% increase compared to previous year.
Average pay of disclosed executives at Peregrine Pharmaceuticals
Nicholas S. Green, Chief Executive Officer, received $6.2M in total, which increased by 117% compared to 2021. 75% of Green's compensation, or $4.6M, was in stock awards. Green also received $895K in non-equity incentive plan, $600K in salary, as well as $44K in other compensation.
Daniel R. Hart, Chief Financial Officer, received a compensation package of $2.1M, which increased by 53% compared to previous year. 61% of the compensation package, or $1.3M, was in stock awards.
Mark R. Ziebell, General Counsel, earned $1.3M in 2022, a 22% increase compared to previous year.
Peregrine Pharmaceuticals' fiscal year ends on April 30.
Related executives
You may also like
Source: SEC filing on August 29, 2022.